Perioperative Lidocaine for Lung Protection in Infants Undergoing Cardiac Surgery

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 320 participants.

Also called NCT07499154

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 320 participants (planned count) (from the registry)
Sponsor
The Children's Hospital of Zhejiang University School of Medicine (from the registry)
Registry
  • NCT NCT07499154
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07499154. Randomized; quadruple masking; primary purpose prevention. Start 2026-04-01 (anticipated); primary completion 2027-12-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Perioperative Lidocaine for Lung Protection in Infants Undergoing Cardiac Surgery
Acronym
PLICS
Condition
Congenital Heart Disease
Condition
Postoperative Pulmonary Complications
Condition
Acute Lung Injury
Intervention (Drug)
Lidocaine %2 ampoule
Intervention (Drug)
Normal Saline (0.9% NaCl)
Lead sponsor
The Children's Hospital of Zhejiang University School of Medicine (class: other)

Record details

Record id
cardio:ct-nct07499154
Content hash
c63a4be390b8276d33dfa22b3f6230c50179ff6270f924a38e0be0c94a5be2db